Back to Search

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  • Protocol Number: 202002050
  • Principal Investigator: Rohatgi, Anjali
  • Cancer Types: Lung

For more information on this trial, contact us here:


Brief Summary

Protocol Interventions